Rapid Quantification of Oxidized and Reduced Forms of Glutathione Using Ortho -phthalaldehyde in Cultured Mammalian Cells In Vitro
June 28th, 2024
Quantification of both oxidized and reduced forms of glutathione (GSSG and GSH, respectively) has been achieved through the use of Ortho-phthalaldehyde (OPA). OPA becomes highly fluorescent once conjugated to GSH but is unable to conjugate GSSG until reduced. Here, we describe a multiparametric assay to quantify both using protein quantification for normalization.
We aim to offer a novel means to quantify thio concentration with a specific focus on the GSH and GSSG concentrations of the various cell lines that can be performed in situ. We consider this a useful protocol for the scientific community. Numerous efforts have been made to detect niche and specific biomarkers of interest of reactive oxygen species.
And several have found great interest in detecting short-lived reactive oxygen species, such as radical detection and small molecules such as hydroxyls and singlet oxygen. One key challenge for several institutions has been the ability to accurately and specifically detect biomarkers of interest without the need of expensive equipment or laborious processes. This protocol allows for multi-parametric analysis, allowing for normalization of data without the need for separate protocols.
And remove several stages found in other assays that are highly time consumptive, present incompatible reagents, or use reagents hazardous to health. The Nanomaterial Safety Group will continue to assess various nanomaterials and polymers for the effect they may have on human health. We consider this protocol an essential part of our toolkit in achieving this goal, as this protocol can potentially be multiplexed to detect additional biomarkers.
To begin, prepare all the required materials for the assay. For GSH standards, add 40 microliters of total glutathione buffer to each well. Next, aspirate the media from each well of a plate containing the cell pellet and wash the cell three times with ice cold PBS.
Prepare the calibration range with 10 microliters of glutathione and double distilled water as blank in triplicates. For desired target quantification, incubate the washed cells with the appropriate mixtures in an orbital shaker at 300 RPM for two minutes. Then add five microliters of 0.01 molar Tris 2-carboxyethyl phosphine solution to each well and incubate again for 10 minutes.
Next, centrifuge the plate at 200 G for five minutes. And transfer 25 microliters from each sample well to a separate, clear 96 well plate for protein quantification. Then add 170 microliters of working ortho-phthaldehyde solution to each well containing 30 microliters of samples.
To shield the plate from light, cover it thoroughly with a foil and incubate it in the orbital shaker for 15 minutes. Finally, read the fluorescence using a plate reader at 340 nanometers excitation and 450 nanometers emission. A-549 cells treated with various nanomaterials showed different glutathione disulfide ratios in this assay.
And the highest value was observed for the cells treated with 125 micrograms per milliliter of silver.
Overview
This study presents a novel protocol for quantifying the concentrations of reduced (GSH) and oxidized (GSSG) glutathione in various cell lines. The method utilizes Ortho-phthalaldehyde (OPA) for fluorescence detection, allowing for efficient normalization of data without the need for extensive procedures.
Key Study Components
Area of Science
- Neuroscience
- Biochemistry
- Cell Biology
Background
- Reactive oxygen species are important biomarkers in various biological processes.
- Accurate detection of GSH and GSSG is crucial for understanding oxidative stress.
- Existing methods can be expensive and time-consuming.
- This protocol aims to simplify the quantification process.
Purpose of Study
- To provide a reliable method for quantifying GSH and GSSG concentrations.
- To facilitate in situ analysis in different cell lines.
- To reduce the complexity and time required for existing assays.
Methods Used
- Preparation of GSH standards and calibration ranges.
- Washing and incubating cell pellets with specific reagents.
- Using OPA for fluorescence detection of glutathione.
- Reading fluorescence at specified excitation and emission wavelengths.
Main Results
- A-549 cells exhibited varying GSH/GSSG ratios when treated with different nanomaterials.
- The highest GSSG levels were observed with 125 µg/mL silver treatment.
- The assay demonstrated effective normalization of protein quantification.
- Results indicate potential for multiplexing to detect additional biomarkers.
Conclusions
- This protocol offers a streamlined approach for glutathione quantification.
- It can be integrated into broader studies of oxidative stress and biomarkers.
- The method is accessible and does not require expensive equipment.
Frequently Asked Questions
Executive Industry Relevance
Quantitative assessment of reduced and oxidized glutathione in cultured mammalian cells is critical for evaluating cellular redox status and oxidative stress response in early drug discovery. This OPA-based assay enables rapid, multiplexed quantification of GSH and GSSG, supporting robust biomarker analysis without the need for specialized instrumentation. The protocol's compatibility with normalization and cytotoxicity assays streamlines data integration across discovery and preclinical workflows.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct measurement of cellular antioxidant capacity for mechanistic de-risking.
- Supports functional validation of oxidative stress pathways in disease-relevant models.
- Facilitates rapid hypothesis testing for target engagement and pathway modulation.
Screening & Assay Development
- Provides a standardized, quantitative readout for high-throughput compound screening.
- Allows for reproducible assessment of redox modulation across diverse cell lines.
- Integrates protein normalization and cytotoxicity assessment for multiparametric outputs.
Translational & Preclinical Research
- Aligns oxidative stress biomarker quantification with translational endpoints.
- Enables continuity from in vitro discovery to preclinical model validation.
- Supports risk-adjusted advancement decisions based on cellular redox state.
Pipeline & Workflow Integration
This OPA-based glutathione quantification method fits within the early discovery to preclinical continuum, enabling seamless integration of redox biomarker analysis into lead identification and mechanistic studies.
- Discovery Biology: Supports hypothesis-driven interrogation of oxidative stress pathways and target validation.
- Screening: Delivers quantitative, reproducible outputs suitable for compound triage and assay standardization.
- Analytics: Provides robust fluorescence-based measurements for comparative analysis of cellular redox status.
- Translational Research: Bridges in vitro findings with preclinical biomarker strategies when oxidative stress is a relevant endpoint.
- Enterprise Reuse: Offers a scalable, adaptable platform for redox biomarker quantification across multiple programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in oxidative stress pathway modulation and target validation.
- Operational Value: Reduces assay complexity, time, and hazardous reagent use while enabling multiplexed outputs.
- Strategic Value: Improves go/no-go decision-making by integrating redox biomarkers with cytotoxicity and protein normalization data.
- Portfolio Impact: Supports risk-adjusted prioritization of assets based on mechanistic and biomarker-driven insights.
Implementation Considerations
- Requires expertise in fluorescence-based assay setup and data interpretation.
- Needs access to a fluorescence plate reader and standard cell culture infrastructure.
- Demands cross-team standardization for normalization and cytotoxicity assessment integration.
- Adaptable to various mammalian cell lines with protocol optimization as needed.
- Multiplexing potential for additional biomarkers depends on reagent compatibility and validation.
